TRPV1 receptor in expression of opioid-induced hyperalgesia.
Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia.


CONCLUSIONS
Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.
Vardanyan
Anna
A
Department of Pharmacology, University of Arizona, Tucson, Arizona 85724, USA.
Wang
Ruizhong
R
Vanderah
Todd W
TW
Ossipov
Michael H
MH
Lai
Josephine
J
Porreca
Frank
F
King
Tamara
T
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D005727:Ganglia, Spinal / Q000378:metabolism; D006930:Hyperalgesia / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology*; D006941:Hyperesthesia / Q000378:metabolism / Q000503:physiopathology; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D010147:Pain Measurement / Q000379:methods; D017288:Pain Threshold / Q000187:drug effects* / Q000523:psychology; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014110:Touch / Q000187:drug effects
D000701:Analgesics, Opioid; D050916:TRPV Cation Channels; C493921:TRPV1 protein, mouse; D009020:Morphine
J Neurosci. 2003 Sep 10;23(23):8370-9
12967999
Semin Cell Dev Biol. 2006 Oct;17(5):582-91
17196854
Neuroscience. 2003;121(3):815-24
14568039
Nature. 2000 May 11;405(6783):183-7
10821274
J Neurosci. 2000 Sep 15;20(18):7074-9
10995854
Pain. 2001 Feb 1;90(1-2):91-6
11166974
Neuroscience. 1996 Jan;70(1):201-9
8848125
Pflugers Arch. 2005 Oct;451(1):151-9
15909179
Neuron. 2002 Sep 26;36(1):57-68
12367506
Ugeskr Laeger. 1995 Jun 5;157(23):3307-10
7543228
Pain. 2005 Aug;116(3):276-288
15964684
Anesthesiology. 1986 Oct;65(4):449
3767054
Neurosci Lett. 1989 Jan 30;96(3):247-52
2566136
J Pain Symptom Manage. 2003 Aug;26(2):769-75
12906962
Pain. 1994 Nov;59(2):313-316
7892029
Neurosci Lett. 2006 Oct 23;407(2):156-61
16959420
J Neurosci. 2005 Jan 12;25(2):409-16
15647484
Pharmacol Biochem Behav. 1999 Feb;62(2):381-8
9972707
EMBO J. 2005 Dec 21;24(24):4211-23
16319926
J Neurosci. 2002 Aug 1;22(15):6773-80
12151557
Neuroscience. 1992 Aug;49(3):693-8
1380138
J Neurosci. 2001 Jun 1;21(11):4074-80
11356895
Pain. 1991 Dec;47(3):337-339
1784504
J Neurobiol. 2004 Oct;61(1):126-48
15362157
J Neurosci. 1994 Apr;14(4):2301-12
7908958
Pain. 1997 Aug;72(1-2):253-60
9272810
J Neurosci. 1996 Apr 1;16(7):2342-51
8601814
J Clin Psychiatry. 2002;63 Suppl 11:6-10
12562137
J Neurosci Methods. 1994 Jul;53(1):55-63
7990513
Neuroscience. 2000;99(3):529-39
11029544
J Neurosci. 2002 Aug 1;22(15):6747-55
12151554
Eur J Pharmacol. 1994 Feb 21;253(1-2):45-51
8013548
Science. 1999 Nov 19;286(5444):1558-61
10567262
J Pharmacol Exp Ther. 2003 Jan;304(1):56-62
12490575
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7658-63
10393876
Pain. 2001 May;92(1-2):5-9
11323121
J Pharmacol Exp Ther. 2005 Apr;313(1):474-84
15615864
Pain. 1996 Sep;67(1):179-188
8895246
Nature. 1997 Oct 23;389(6653):816-24
9349813
Neuroscience. 2007 Mar 16;145(2):676-85
17239544
J Physiol. 2001 Aug 1;534(Pt 3):813-25
11483711
Regul Pept. 1993 Jul 2;46(1-2):150-4
7692483
Pain. 1988 Jan;32(1):77-88
3340425
Drug Alcohol Depend. 2001 Jul 1;63(2):139-46
11376918
Pain. 1995 Sep;62(3):259-274
8657426
Brain Res. 1987 Aug 18;418(1):201-3
3664271
J Neurosci. 2002 Oct 15;22(20):9086-98
12388616
Nat Rev Neurosci. 2001 Feb;2(2):83-91
11252998
J Neurosurg Anesthesiol. 1997 Apr;9(2):146-8
9100184
Am J Physiol Cell Physiol. 2004 Aug;287(2):C558-63
15084474
Ann Oncol. 2005 May;16 Suppl 4:iv132-135
15923413
Brain Res. 2002 Dec 20;958(1):28-35
12468027
J Neurophysiol. 1991 Jul;66(1):190-211
1919666
Anesthesiology. 2000 Feb;92(2):465-72
10691234
J Med Chem. 2004 May 20;47(11):2717-23
15139748
Eur J Pharmacol. 1990 Aug 10;184(2-3):207-12
2150374
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2622-6
7535928
J Pharmacol Exp Ther. 1988 Feb;244(2):501-7
3346833
J Neurosci. 2001 Jan 1;21(1):279-86
11150345
Annu Rev Neurosci. 2001;24:487-517
11283319
Eur J Pharmacol. 1994 Sep 22;263(1-2):203-5
7821354
Anesthesiology. 1986 May;64(5):590-7
2938524
Br J Pharmacol. 2000 Nov;131(5):875-84
11053206
Proc Natl Acad Sci U S A. 1988 Jan;85(2):622-6
2893375
Science. 2000 Apr 14;288(5464):306-13
10764638
Annu Rev Pharmacol Toxicol. 1980;20:441-62
7387124
J Pharmacol Exp Ther. 2002 Jan;300(1):265-72
11752125
J Neurosci. 1997 Oct 15;17(20):8049-60
9315923
Eur J Neurosci. 2001 Jun;13(11):2105-14
11422451
J Pharmacol Exp Ther. 2003 Jul;306(1):387-93
12721336
Neurosci Lett. 1998 Jul 10;250(3):193-6
9708865
Science. 1997 Oct 10;278(5336):275-9
9323204
J Pharmacol Exp Ther. 1985 Nov;235(2):282-6
4057070
J Neurophysiol. 2006 May;95(5):3086-96
16467418
Neuroscience. 1998 May;84(2):583-9
9539228
Pain. 1993 Oct;55(1):93-97
8278214